Identifying obesity risks in preterm infants
Preventing Obesity in Preterm Infants
This study is looking at how the growth of fat in babies born a bit early (between 32 and 36 weeks) can help us understand their chances of becoming overweight or having health problems later on, especially considering things like their mom's weight and diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10886614 on NIH RePORTER |
What this research studies
This research investigates how the development of fat tissue in preterm infants can indicate their risk for obesity and related health issues later in life. It focuses on infants born moderately preterm, between 32 and 36 weeks of gestation, and examines how factors like maternal obesity and diabetes affect their growth and metabolism. By using advanced imaging techniques and biological markers, the study aims to identify early signs of obesity risk, which could lead to targeted interventions for at-risk infants.
Who could benefit from this research
Good fit: Ideal candidates for this research are infants born moderately preterm, particularly those whose mothers have experienced obesity or gestational diabetes.
Not a fit: Patients who are not preterm or do not have a family history of obesity or metabolic disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help identify preterm infants at risk for obesity, allowing for early interventions to improve their long-term health outcomes.
How similar studies have performed: Previous research has shown promising results in identifying obesity risks in preterm infants using similar methodologies, suggesting that this approach could be effective.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Buck, Catherine O — Yale University
- Study coordinator: Buck, Catherine O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.